Nathan Beahm
@nathanbeahm.bsky.social
Associate Clinical Professor, University of Alberta. Academic Pharmacist. Infectious Diseases, Antimicrobial Stewardship, Pain Management.
Reposted by Nathan Beahm
🚨 IDSA has released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs)!
The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.
View guidelines: bit.ly/4lUjN1a
The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.
View guidelines: bit.ly/4lUjN1a
July 17, 2025 at 7:07 PM
🚨 IDSA has released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs)!
The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.
View guidelines: bit.ly/4lUjN1a
The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.
View guidelines: bit.ly/4lUjN1a
Happy #IDPharmacistsDay to those who celebrate! (which should be everyone, amirite?😉)
Infectious Diseases Pharmacists Day is Thursday! Join the chat here 5/22 12-1PMEST help us celebrate the amazing work ID pharmacists do every day. #IDPharmacistsDay, #SIDPAdvocacy, #PharmacistsLeadingChange @sidpharm.bsky.social @accpinfdprn.bsky.social
May 22, 2025 at 3:40 PM
Happy #IDPharmacistsDay to those who celebrate! (which should be everyone, amirite?😉)
Reposted by Nathan Beahm
💉 In a small RCT of IL-7 for refractory MAC lung disease, IL-7 increased lymphocyte counts but failed to convert sputum cultures.
Structural lung disease may trump immune dysfunction in driving outcomes.
journals.sagepub.com/doi/full/10....
Structural lung disease may trump immune dysfunction in driving outcomes.
journals.sagepub.com/doi/full/10....
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
May 12, 2025 at 1:10 PM
💉 In a small RCT of IL-7 for refractory MAC lung disease, IL-7 increased lymphocyte counts but failed to convert sputum cultures.
Structural lung disease may trump immune dysfunction in driving outcomes.
journals.sagepub.com/doi/full/10....
Structural lung disease may trump immune dysfunction in driving outcomes.
journals.sagepub.com/doi/full/10....
A bit late posting, but our systematic review on the role of #antidepressants in managing chronic temporomandibular disorder pain was published: doi.org/10.1111/joor....
Limited studies suggested benefit, particularly for agents with both noradrenergic and serotonergic activity. #TMD #pain
Limited studies suggested benefit, particularly for agents with both noradrenergic and serotonergic activity. #TMD #pain
Beyond Depression: The Role of Antidepressants in Managing Chronic Temporomandibular Disorders. A Systematic Review
Background
Chronic temporomandibular disorder (TMD) pain significantly impairs quality of life and lacks universally effective treatments. Antidepressants, traditionally used for mood disorders, hav.....
doi.org
May 7, 2025 at 11:41 PM
A bit late posting, but our systematic review on the role of #antidepressants in managing chronic temporomandibular disorder pain was published: doi.org/10.1111/joor....
Limited studies suggested benefit, particularly for agents with both noradrenergic and serotonergic activity. #TMD #pain
Limited studies suggested benefit, particularly for agents with both noradrenergic and serotonergic activity. #TMD #pain
Reposted by Nathan Beahm
New review article on management of S. aureus bacteraemia: jamanetwork.com/journals/jam...
@jama.com @vancefowler.bsky.social #IDSky
Check out the gorgeous Figure which brings together elements of pathogenesis and management: (thread)
@jama.com @vancefowler.bsky.social #IDSky
Check out the gorgeous Figure which brings together elements of pathogenesis and management: (thread)
Staphylococcus aureus Bacteremia: A Review
This narrative review summarizes current evidence on the epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment of Staphylococcus aureus bacteremia.
jamanetwork.com
April 7, 2025 at 3:52 PM
New review article on management of S. aureus bacteraemia: jamanetwork.com/journals/jam...
@jama.com @vancefowler.bsky.social #IDSky
Check out the gorgeous Figure which brings together elements of pathogenesis and management: (thread)
@jama.com @vancefowler.bsky.social #IDSky
Check out the gorgeous Figure which brings together elements of pathogenesis and management: (thread)
Reposted by Nathan Beahm
My replies are perpetually full of anti-vaxxers these days telling me about polio vaccines.
Not shockingly, most of what they are saying is wrong. Luckily, I trained with Vincent Racaniello & he taught me a few things about poliovirus.
So let’s discuss the king of the Picornaviridae👇🏻
Not shockingly, most of what they are saying is wrong. Luckily, I trained with Vincent Racaniello & he taught me a few things about poliovirus.
So let’s discuss the king of the Picornaviridae👇🏻
December 18, 2024 at 1:07 PM
My replies are perpetually full of anti-vaxxers these days telling me about polio vaccines.
Not shockingly, most of what they are saying is wrong. Luckily, I trained with Vincent Racaniello & he taught me a few things about poliovirus.
So let’s discuss the king of the Picornaviridae👇🏻
Not shockingly, most of what they are saying is wrong. Luckily, I trained with Vincent Racaniello & he taught me a few things about poliovirus.
So let’s discuss the king of the Picornaviridae👇🏻
Interesting article in #JAC on loading dose of #clofazimine in nontuberculous mycobacterial disease. A 4-week loading dose of 300 mg daily resulted in faster time to steady-state-like concentrations (3.8 vs 5.3 months) and was deemed safe and well-tolerated.
doi.org/10.1093/jac/... #IDSky #NTM
doi.org/10.1093/jac/... #IDSky #NTM
A loading dose of clofazimine to rapidly achieve steady-state-like concentrations in patients with nontuberculous mycobacterial disease
AbstractObjectives. Clofazimine is a promising drug for the treatment of nontuberculous mycobacterial (NTM) diseases. Accumulation of clofazimine to reach
doi.org
December 12, 2024 at 8:10 PM
Interesting article in #JAC on loading dose of #clofazimine in nontuberculous mycobacterial disease. A 4-week loading dose of 300 mg daily resulted in faster time to steady-state-like concentrations (3.8 vs 5.3 months) and was deemed safe and well-tolerated.
doi.org/10.1093/jac/... #IDSky #NTM
doi.org/10.1093/jac/... #IDSky #NTM
Reposted by Nathan Beahm
BLUESKY MEGA-THREAD
Altmetric is thrilled and also LITERALLY RELIEVED to officially announce:
We are now tracking research attention as it happens on Bluesky!
We have been picking up posts on the site since late Oct.
Our team is on Bluesky all day answering questions.
Let's get into it!
Altmetric is thrilled and also LITERALLY RELIEVED to officially announce:
We are now tracking research attention as it happens on Bluesky!
We have been picking up posts on the site since late Oct.
Our team is on Bluesky all day answering questions.
Let's get into it!
December 3, 2024 at 2:00 PM
BLUESKY MEGA-THREAD
Altmetric is thrilled and also LITERALLY RELIEVED to officially announce:
We are now tracking research attention as it happens on Bluesky!
We have been picking up posts on the site since late Oct.
Our team is on Bluesky all day answering questions.
Let's get into it!
Altmetric is thrilled and also LITERALLY RELIEVED to officially announce:
We are now tracking research attention as it happens on Bluesky!
We have been picking up posts on the site since late Oct.
Our team is on Bluesky all day answering questions.
Let's get into it!
Reposted by Nathan Beahm
Oral cephalosporins for pyelonephritis?!
🆕️⚡️⚡️COPY-ED
Multicenter, retrospective study
N=851
No difference in 14-day pyelonephritis treatment failure for oral cephalosporins* vs FQ/TMP-SMX for outpatient pyelonephritis in the ED #idsky #medsky
* Mostly cephalexin
www.sciencedirect.com/science/arti...
🆕️⚡️⚡️COPY-ED
Multicenter, retrospective study
N=851
No difference in 14-day pyelonephritis treatment failure for oral cephalosporins* vs FQ/TMP-SMX for outpatient pyelonephritis in the ED #idsky #medsky
* Mostly cephalexin
www.sciencedirect.com/science/arti...
November 25, 2024 at 12:42 PM
Oral cephalosporins for pyelonephritis?!
🆕️⚡️⚡️COPY-ED
Multicenter, retrospective study
N=851
No difference in 14-day pyelonephritis treatment failure for oral cephalosporins* vs FQ/TMP-SMX for outpatient pyelonephritis in the ED #idsky #medsky
* Mostly cephalexin
www.sciencedirect.com/science/arti...
🆕️⚡️⚡️COPY-ED
Multicenter, retrospective study
N=851
No difference in 14-day pyelonephritis treatment failure for oral cephalosporins* vs FQ/TMP-SMX for outpatient pyelonephritis in the ED #idsky #medsky
* Mostly cephalexin
www.sciencedirect.com/science/arti...
Reposted by Nathan Beahm
🚨 Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections
BALANCE trial publication is here !
#IDsky #Medsky
@idjclub.bsky.social
www.nejm.org/doi/full/10....
BALANCE trial publication is here !
#IDsky #Medsky
@idjclub.bsky.social
www.nejm.org/doi/full/10....
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM
Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. In a multicenter, non...
www.nejm.org
November 20, 2024 at 1:10 PM
🚨 Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections
BALANCE trial publication is here !
#IDsky #Medsky
@idjclub.bsky.social
www.nejm.org/doi/full/10....
BALANCE trial publication is here !
#IDsky #Medsky
@idjclub.bsky.social
www.nejm.org/doi/full/10....
Reposted by Nathan Beahm
We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
Action Intent Links | Bluesky
Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...
docs.bsky.app
November 18, 2024 at 2:48 PM
We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
docs.bsky.app/docs/advance...
#AcademicSky #HigherEd #Altmetrics
Reposted by Nathan Beahm
MYCOPLASMA PNEUMONIAE
This cheeky little intracellular bacteria seems to be up to mischief with kids in the USA at the moment
A quick thread on this bug, what's going on, and what to do (or not do!) about it
#IDSky #PedSky #PedsIDSky 🧪
1/🧵
This cheeky little intracellular bacteria seems to be up to mischief with kids in the USA at the moment
A quick thread on this bug, what's going on, and what to do (or not do!) about it
#IDSky #PedSky #PedsIDSky 🧪
1/🧵
November 12, 2024 at 1:20 PM
MYCOPLASMA PNEUMONIAE
This cheeky little intracellular bacteria seems to be up to mischief with kids in the USA at the moment
A quick thread on this bug, what's going on, and what to do (or not do!) about it
#IDSky #PedSky #PedsIDSky 🧪
1/🧵
This cheeky little intracellular bacteria seems to be up to mischief with kids in the USA at the moment
A quick thread on this bug, what's going on, and what to do (or not do!) about it
#IDSky #PedSky #PedsIDSky 🧪
1/🧵
Reposted by Nathan Beahm
My first #IDSky post will be a shameless promotion of our new UTI WikiGuideline!
jamanetwork.com/journals/jam...
Of 37 questions, only 6 had enough data to fully meet criteria for a clear recommendation!
jamanetwork.com/journals/jam...
Of 37 questions, only 6 had enough data to fully meet criteria for a clear recommendation!
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections
This consensus statement creates a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation strength.
jamanetwork.com
November 8, 2024 at 3:04 AM
My first #IDSky post will be a shameless promotion of our new UTI WikiGuideline!
jamanetwork.com/journals/jam...
Of 37 questions, only 6 had enough data to fully meet criteria for a clear recommendation!
jamanetwork.com/journals/jam...
Of 37 questions, only 6 had enough data to fully meet criteria for a clear recommendation!
👋 Hello friends, old and new! This move to 🦋 feels like a mass migration to a new island and I'm excited to see everyone showing up here. Enjoying the weather here so far. Looking forward to interacting and learning with and from you on this platform!
November 9, 2024 at 5:46 AM
👋 Hello friends, old and new! This move to 🦋 feels like a mass migration to a new island and I'm excited to see everyone showing up here. Enjoying the weather here so far. Looking forward to interacting and learning with and from you on this platform!